Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Name: Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
License: Public Domain

Inhibrx Biosciences, Inc

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

gastric-cancer head-and-neck-cancer melanoma non-small-cell-lung-cancer renal-cell-carcinoma

solid tumor, non-small cell lung cancer, head and neck cancer, melanoma, gastric cancer, renal cell carcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 238110
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.